Trial Profile
Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients Based on Assessment of Endogenous Analgesia Capabilities.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2017
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 10 Oct 2017 Status changed from recruiting to completed.
- 03 Jun 2011 New trial record